NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
22.56
+0.36 (1.62%)
At close: Jul 21, 2025, 4:00 PM
22.10
-0.46 (-2.04%)
Pre-market: Jul 22, 2025, 8:44 AM EDT
NAMS Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$41.11
Upside
+82.23%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Initiates $27 | Hold | Initiates | $27 | +19.68% | Jul 17, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +86.17% | Jun 17, 2025 |
| Needham | Needham | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +77.30% | Jun 12, 2025 |
| Stifel | Stifel | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +95.04% | Jun 10, 2025 |
| Needham | Needham | Strong Buy Maintains $42 → $40 | Strong Buy | Maintains | $42 → $40 | +77.30% | May 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +86.17% | Apr 8, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $47 → $52 | Buy | Maintains | $47 → $52 | +130.50% | Feb 27, 2025 |
| Needham | Needham | Strong Buy Maintains $46 → $42 | Strong Buy | Maintains | $46 → $42 | +86.17% | Feb 27, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $40 | Buy | Reiterates | $40 | +77.30% | Jan 28, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $40 | Buy | Reiterates | $40 | +77.30% | Jan 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +112.77% | Jan 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +112.77% | Dec 30, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $35 → $47 | Buy | Maintains | $35 → $47 | +108.33% | Dec 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +59.57% | Dec 5, 2024 |
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +59.57% | Nov 21, 2024 |
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +59.57% | Nov 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.